Expression and Antimicrobial Function of Beta-Defensin 1 in the Lower Urinary Tract

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Becknell, Brian ^a,b   Spencer, John David ^a,b   Carpenter, Ashley R ^b,c   Chen, Xi ^b   Singh, Aspinder ^c   Ploeger, Suzanne ^c   Kline, Jennifer ^b   Ellsworth, Patrick ^d   Li, Birong ^b   Proksch, Ehrhardt ^e   Schwaderer, Andrew L ^a,b   Hains, David S ^a,b   Justice, Sheryl S ^b   McHugh, Kirk M ^b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 14; BETA DEFENSIN 3; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; BLADDER; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; URETER; URINARY TRACT; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; UROTHELIUM; WILD TYPE;

ANIMALS; ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; URINARY TRACT; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84886927256     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077714     Document Type: Article

References (53)

1. Hunstad DA, Justice SS, (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol 64: 203-221. doi:10.1146/annurev.micro.112408.134258. PubMed: 20825346.
2. Ragnarsdóttir B, Svanborg C, (2012) Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol 27: 2017-2029. doi:10.1007/s00467-011-2089-1. PubMed: 22327887.
3. Underwood MA, Bevins CL, (2010) Defensin-barbed innate immunity: clinical associations in the pediatric population. Pediatrics 125: 1237-1247. doi:10.1542/peds.2009-3289. PubMed: 20478936.
4. Selsted ME, Ouellette AJ, (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6: 551-557. doi:10.1038/ni1206. PubMed: 15908936.
5. Hazlett L, Wu M, (2011) Defensins in innate immunity. Cell Tissue Res 343: 175-188. doi:10.1007/s00441-010-1022-4. PubMed: 20730446.
6. Ganz T, (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720. doi:10.1038/nri1180. PubMed: 12949495.
7. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, et al. (2002) Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A 99: 2129-2133. doi:10.1073/pnas.042692699. PubMed: 11854508.
8. Bensch KW, Raida M, Mägert HJ, Schulz-Knappe P, Forssmann WG, (1995) hBD-1: a novel beta-defensin from human plasma. FEBS Lett 368: 331-335. doi:10.1016/0014-5793(95)00687-5. PubMed: 7628632.
9. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, et al. (1998) Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101: 1633-1642. doi:10.1172/JCI1861. PubMed: 9541493.
10. Townes CL, Ali A, Robson W, Pickard R, Hall J, (2011) Tolerance of bacteriuria after urinary diversion is linked to antimicrobial peptide activity. Urology 77(2):: e1-8. PubMed: 21094991.
11. Zucht HD, Grabowsky J, Schrader M, Liepke C, Jürgens M, et al. (1998) Human beta-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. Eur J Med Res 3: 315-323. PubMed: 9682027.
12. Hiratsuka T, Nakazato M, Ihi T, Minematsu T, Chino N, et al. (2000) Structural analysis of human beta-defensin-1 and its significance in urinary tract infection. Nephron 85: 34-40. doi:10.1159/000045627. PubMed: 10773753.
13. Huttner KM, Kozak CA, Bevins CL, (1997) The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1. FEBS Lett 413: 45-49. doi:10.1016/S0014-5793(97)00875-2. PubMed: 9287114.
14. Bals R, Goldman MJ, Wilson JM, (1998) Mouse beta-defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract. Infect Immun 66: 1225-1232. PubMed: 9488417.
15. Morrison GM, Davidson DJ, Kilanowski FM, Borthwick DW, Crook K, et al. (1998) Mouse beta defensin-1 is a functional homolog of human beta defensin-1. Mamm Genome 9: 453-457. doi:10.1007/s003359900795. PubMed: 9585433.
16. Morrison G, Kilanowski F, Davidson D, Dorin J, (2002) Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun 70: 3053-3060. doi:10.1128/IAI.70.6.3053-3060.2002. PubMed: 12010997.
17. Spencer JD, Schwaderer AL, Dirosario JD, McHugh KM, McGillivary G, et al. (2011) Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int 80: 174-180. doi:10.1038/ki.2011.109. PubMed: 21525852.
18. Moser C, Weiner DJ, Lysenko E, Bals R, Weiser JN, et al. (2002) beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect Immun 70: 3068-3072. doi:10.1128/IAI.70.6.3068-3072.2002. PubMed: 12010999.
19. Hung CS, Dodson KW, Hultgren SJ, (2009) A murine model of urinary tract infection. Nat Protoc 4: 1230-1243. doi:10.1038/nprot.2009.116. PubMed: 19644462.
20. Bolton M, Horvath DJ Jr, Li B, Cortado H, Newsom D, et al. (2012) Intrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitis. PLOS ONE 7: e33897. doi:10.1371/journal.pone.0033897. PubMed: 22470490.
21. Thai KH, Thathireddy A, Hsieh MH, (2010) Transurethral induction of mouse urinary tract infection. J Vis Exp. PubMed: 20729806.
22. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. doi:10.1038/nprot.2008.73. PubMed: 18546601.
23. Ahrens K, Schunck M, Podda GF, Meingassner J, Stuetz A, et al. (2011) Mechanical and metabolic injury to the skin barrier leads to increased expression of murine beta-defensin-1,-3, and-14. J Invest Dermatol 131: 443-452. doi:10.1038/jid.2010.289. PubMed: 20944649.
24. Spencer JD, Schwaderer AL, Wang H, Bartz J, Kline J, et al. (2013) Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tract. Kidney Int 83: 615-25. PubMed: 23302724.
25. Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, et al. (2004) Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol 286: F795-F802. doi:10.1152/ajprenal.00357.2003. PubMed: 14665435.
26. Hunstad DA, Justice SS, Hung CS, Lauer SR, Hultgren SJ, (2005) Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun 73: 3999-4006. doi:10.1128/IAI.73.7.3999-4006.2005. PubMed: 15972487.
27. Storm DW, Patel AS, Horvath DJ Jr, Li B, Koff SA, et al. (2012) Relationship among bacterial virulence, bladder dysfunction, vesicoureteral reflux and patterns of urinary tract infection in children. J Urol 188: 236-241. doi:10.1016/j.juro.2012.03.025. PubMed: 22595065.
28. Billips BK, Forrestal SG, Rycyk MT, Johnson JR, Klumpp DJ, et al. (2007) Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun 75: 5353-5360. doi:10.1128/IAI.00922-07. PubMed: 17724068.
29. Billips BK, Schaeffer AJ, Klumpp DJ, (2008) Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect Immun 76: 3891-3900. doi:10.1128/IAI.00069-08. PubMed: 18559433.
30. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, et al. (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7: 180-185. doi:10.1038/84627. PubMed: 11175848.
31. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V, (2004) Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun 72: 2772-2779. doi:10.1128/IAI.72.5.2772-2779.2004. PubMed: 15102787.
32. Sperandio B, Regnault B, Guo J, Zhang Z, Stanley SL Jr, et al. (2008) Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med 205: 1121-1132. doi:10.1084/jem.20071698. PubMed: 18426984.
33. Ryan LK, Dai J, Yin Z, Megjugorac N, Uhlhorn V, et al. (2011) Modulation of human beta-defensin-1 (hBD-1) in plasmacytoid dendritic cells (PDC), monocytes, and epithelial cells by influenza virus, Herpes simplex virus, and Sendai virus and its possible role in innate immunity. J Leukoc Biol 90: 343-356. doi:10.1189/jlb.0209079. PubMed: 21551252.
34. Quality AfHra, (2010) he Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample (NIS).
35. Chromek M, Slamová Z, Bergman P, Kovács L, Podracká L, et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636-641. doi:10.1038/nm1407. PubMed: 16751768.
36. Nitschke M, Wiehl S, Baer PC, Kreft B, (2002) Bactericidal activity of renal tubular cells: the putative role of human beta-defensins. Exp Nephrol 10: 332-337. doi:10.1159/000065296. PubMed: 12381917.
37. Zasloff M, (2007) Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 18: 2810-2816. doi:10.1681/ASN.2007050611. PubMed: 17942949.
38. Spencer JD, Hains DS, Porter E, Bevins CL, DiRosario J, et al. (2012) Human alpha defensin 5 expression in the human kidney and urinary tract. PLOS ONE 7: e31712. doi:10.1371/journal.pone.0031712. PubMed: 22359618.
39. Spencer JD, Schwaderer AL, Becknell B, Watson J, Hains DS, (2013) The innate immune response during urinary tract infection and pyelonephritis. Pediatr Nephrol. PubMed: 23732397.
40. Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, et al. (2004) Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 65: 791-797. doi:10.1111/j.1523-1755.2004.00452.x. PubMed: 14871399.
41. Ganz T, (2001) Antimicrobial proteins and peptides in host defense. Semin Respir Infect 16: 4-10. doi:10.1053/srin.2001.22723. PubMed: 11309707.
42. Ganz T, (2001) Defensins in the urinary tract and other tissues. J Infect Dis 183 (Suppl 1):: S41-S42. doi:10.1086/318838. PubMed: 11171012.
43. Ali AS, Townes CL, Hall J, Pickard RS, (2009) Maintaining a sterile urinary tract: the role of antimicrobial peptides. J Urol 182: 21-28. doi:10.1016/j.juro.2009.02.124. PubMed: 19447447.
44. Zasloff M, (2013) The antibacterial shield of the human urinary tract. Kidney Int 83: 548-550. doi:10.1038/ki.2012.467. PubMed: 23538695.
45. Kline KA, Ingersoll MA, Nielsen HV, Sakinc T, Henriques-Normark B, et al. (2010) Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence. Infect Immun 78: 1943-1951. doi:10.1128/IAI.01235-09. PubMed: 20176795.
46. Hinrichsen K, Podschun R, Schubert S, Schröder JM, Harder J, et al. (2008) Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents Chemother 52: 1876-1879. doi:10.1128/AAC.01308-07. PubMed: 18332171.
47. Bals R, Wang X, Meegalla RL, Wattler S, Weiner DJ, et al. (1999) Mouse beta-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect Immun 67: 3542-3547. PubMed: 10377137.
48. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088. doi:10.1126/science.282.5396.2085. PubMed: 9851930.
49. Kraemer BF, Campbell RA, Schwertz H, Cody MJ, Franks Z, et al. (2011) Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLOS Pathog 7: e1002355.
50. Soruri A, Grigat J, Forssmann U, Riggert J, Zwirner J, (2007) beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol 37: 2474-2486. doi:10.1002/eji.200737292. PubMed: 17705135.
51. Jiang Y, Yang D, Li W, Wang B, Jiang Z, et al. (2012) Antiviral activity of recombinant mouse beta-defensin 3 against influenza A virus in vitro and in vivo. Antivir Chem Chemother 22: 255-262. doi:10.3851/IMP2077. PubMed: 22345365.
52. Barabas N, Röhrl J, Holler E, Hehlgans T, (2012) Beta-defensins activate macrophages and synergize in pro-inflammatory cytokine expression induced by TLR ligands. Immunobiology 218: 1005-10011. PubMed: 23332217.
53. Semple F, Webb S, Li HN, Patel HB, Perretti M, et al. (2010) Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol 40: 1073-1078. doi:10.1002/eji.200940041. PubMed: 20104491.